InsidersTradesSigma
Follow the 코오롱생명과학 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 코오롱생명과학 has published 14 insider filings. The latest transaction was reported on 2 December 2025 (Purchase). Among the most active insiders: 이웅열. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
14 of 14 declarations
Kolon Life Science is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of biopharmaceutical products and innovative therapies.